Form D · Biotechnology
Yiviva, Inc.
New York, NY · CIK 0001732143
Offering snapshot reported Feb 21, 2018 · SEC filing
- Reported sold
- $5M Offering amount: $6.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2018 | Initial | $5,000,005 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-306089
Source: Form D, filed Feb 21, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peikwe Cheng | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
447 Broadway, 2 F
New York, NY, 10013
New York, NY, 10013